Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 5385 (106th)

RU-486 Patient Health and Safety Protection Act

referredUnited States· United States Congress· EN

Introduced

4 October 2000

Last action

20 October 2000 · Referred

Status

Referred to the Subcommittee on Health and Environment.

Sponsors

Sen. Coburn, Tom [R-OK], Rep. Armey, Richard K. [R-TX-26], Rep. DeLay, Tom [R-TX-22], Rep. Watts, J. C., Jr. [R-OK-4], Rep. Smith, Christopher H. [R-NJ-4], Rep. Oberstar, James L. [D-MN-8], Rep. Stupak, Bart [D-MI-1], Rep. Myrick, Sue Wilkins [R-NC-9], Rep. Rahall, Nick J., II [D-WV-3], Rep. Aderholt, Robert B. [R-AL-4], Rep. Baker, Richard H. [R-LA-6], Rep. Shimkus, John [R-IL-15], Rep. Emerson, Jo Ann [R-MO-8], Rep. Schaffer, Bob [R-CO-4], Sen. DeMint, Jim [R-SC], Rep. Doolittle, John T. [R-CA-4], Rep. Wamp, Zach [R-TN-3], Rep. Istook, Ernest J., Jr. [R-OK-5], Rep. Hilleary, Van [R-TN-4], Sen. Burr, Richard [R-NC], Rep. Tancredo, Thomas G. [R-CO-6], Sen. Vitter, David [R-LA], Rep. Pickering, Charles W. "Chip" [R-MS-3], Rep. English, Phil [R-PA-3], Rep. Hayes, Robin [R-NC-8], Rep. Peterson, John E. [R-PA-5], Rep. Barr, Bob [R-GA-7], Rep. Pitts, Joseph R. [R-PA-16], Rep. Dickey, Jay [R-AR-4], Rep. Hostettler, John N. [R-IN-8], Rep. Hoekstra, Peter [R-MI-2], Rep. Largent, Steve [R-OK-1], Rep. Souder, Mark E. [R-IN-3], Rep. Tiahrt, Todd [R-KS-4], Rep. Hayworth, J. D. [R-AZ-5], Rep. Chenoweth-Hage, Helen [R-ID-1], Rep. Johnson, Sam [R-TX-3], Rep. Goode, Virgil H., Jr. [R-VA-5], Rep. Ryun, Jim [R-KS-2], Rep. Bartlett, Roscoe G. [R-MD-6], Rep. Green, Mark [R-WI-8], Rep. Jones, Walter B., Jr. [R-NC-3], Rep. Manzullo, Donald A. [R-IL-16], Rep. Shadegg, John B. [R-AZ-3], Rep. Mica, John L. [R-FL-7], Rep. Forbes, Michael P. [D-NY-1], Rep. Miller, Gary G. [R-CA-42], Sen. Thune, John [R-SD]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

RU-486 Patient Health and Safety Protection Act - Restricts the prescribing of the drug mifepristone (commonly referred to as RU-486, to be marketed as Mifeprex) to physicians who meet specified requirements.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 4 October 2000

    Introduced

    Referred to the House Committee on Commerce.

    Source: IntroReferral

  2. 4 October 2000

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 4 October 2000

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 20 October 2000

    Referred

    Referred to the Subcommittee on Health and Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 4 October 2000

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 4 October 2000

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 4 October 2000

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 53 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.